PARLIAMENTARY WRITTEN QUESTION
(29 November 2024)

From September 2023, the routine shingles vaccination programme changed from the Zostavax vaccine to the two dose Shingrix vaccine, to better protect individuals from the effects of shingles, provide better clinical outcomes, and reduce pressures on the health system. The programme was also expanded, and as a result, almost 1 million more people became eligible for the shingles vaccination.

The expansion of the shingles programme currently includes those turning 65 years old on or after 1 September 2023, as well as those aged 50 years old and over who are at increased risk of serious complications. Once everyone aged 65 to 70 years old has received the vaccine, the eligible age will be reduced to 60 years old. Phasing the roll-out of the shingles vaccination over time to everyone aged 60 years old maximises cost effectiveness and population benefit, ensures consistent messaging over time to maximise coverage, and takes account of National Health Service capacity, all while being consistent with the approach taken by all four nations in the United Kingdom. This is a newly expanded programme, and anyone unsure if they are eligible for the shingles vaccination should check online, on the NHS.UK website, or should speak to their general practice.

In November, the Joint Committee on Vaccination and Immunisation provided advice to the Department on eligibility for the shingles vaccination programme. This included advice that the Government should consider expanding the shingles vaccination offer to include older adult cohorts aged 80 years old and over. The Department will consider this advice and will update in due course.